Search results for "pharmaceutical company"

Daewoong Pharmaceutical Acquires U.S. Cellular Reprogramming Tech to Fast-Track Anti-Aging Therapeutics

Daewoong Pharmaceutical Acquires U.S. Cellular Reprogramming Tech to Fast-Track Anti-Aging Therapeutics

Daewoong Pharmaceutical is accelerating its research and development into anti-aging therapeutics. The company announced on the 21st that it has...
When Recurrent Diarrhea Is More Than a Passing Bug: The Rising Threat of IBD in Young Adults

When Recurrent Diarrhea Is More Than a Passing Bug: The Rising Threat of IBD in Young Adults

When recurring abdominal pain and diarrhea strike, most people first assume they are dealing with a standard bout of gastroenteritis or irritable...
Rejuran Cosmetics Sales Surge 51%: PharmaResearch Finds New Growth Engine

Rejuran Cosmetics Sales Surge 51%: PharmaResearch Finds New Growth Engine

PharmaResearch is successfully diversifying its business model, transitioning from a medical device-centric structure...
Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years

Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years

Being diagnosed with a brain tumor in your 30s or 40s—when you are building your career, raising children, and staying...
Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection

Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection

Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection...
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge

K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge

More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?

Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?

A final decision on the approval of RIMQARTO (anbalcabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T)...
“We Can’t Afford Dad's Medicine”: The Heartbreaking Reality of Late-Stage Cancer Costs

“We Can’t Afford Dad's Medicine”: The Heartbreaking Reality of Late-Stage Cancer Costs

“Should we sell the house? Dad’s medication is just too expensive.” This is the agonizing question keeping a mother in...
Korea’s 40th New Drug ‘Nuviju’ Launches: A Three-Way Battle for the Double-Chin Market

Korea’s 40th New Drug ‘Nuviju’ Launches: A Three-Way Battle for the Double-Chin Market

Medytox is set to shake up the aesthetic medicine industry with the launch of "Nuviju," a new treatment for submental...